working

Sign up to access

Get access to our full offering from over 30 providers

Get access to our full offering from over 30 providers


Get Started
Already a member? Log in here

More Content

More Content

Morning Note – 25 June 2025

Companies: FTC AVG RUA GTC HSP TND BBSN ULTP DUKE POLB

US Tariffs - impact on Cavendish research universe

Companies: 88E AZY LIT HHR GENI FOG TXP FNX 4BB KITW DSCV SDY ALU BILN CLBS PEB EDEN TIDE CNC GHH PEN IGP FTC EBQ IOM KIE LPA RNO MPE SOLI TRI MTC AVG PCIP RUA RBN KBT MBH NANO FEN AGY MAI TSTL SRT POS HSP VNET TAST OMIP CNSL ING SDI DOTD TND TIA BVXP AET RST IKA COST RCN HVO RBD TIME BOWL BBB KMK MRL XPF ARC TGP ASAI TRT SPR BGEO BBSN EMAN KRM VLG IXI SPA GETB PMG PULS USFP XSG HDD BRCK SEA JNEO SWG HAYD GFRD FRP ELIX QTX SAVE CARR TRC W7L JOG DEC ULTP NXR CER CRDL CREO GPM CHAR MPL NESF DUKE XLMDF EXR OPG CMCL BOOM LORD CLX HCM FADL MEX S247 ADF REVB SOM CORA POLB VINO RCFX BLZE AMCO ZAM

Poolbeg+ (POLB, House Stock at 3p) - Primed to go

Companies: Poolbeg Pharma PLC

Poolbeg Pharma granted FDA Orphan Drug Designation for treatment in cancer immunotherapy

Companies: Poolbeg Pharma PLC

Poolbeg Pharma - £4.9m gross proceeds secured, potential catalysts ahead

Companies: Poolbeg Pharma PLC

© Research Tree 2025

  • Apple Store
  • Play Store

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top